Author

Nicole M. Warrington

Washington University in St. LouisPrimary ORCID profile (0000-0003-4195-775X · 17 papers)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Nicole M. WarringtoniD17 papers · The University of Queensland

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Approach:machine learning (classical)· 1

Frequent Co-Authors

Albert H. Kim· 1 shared Brian D. MueggeiD· 1 shared Eduardo Carrasco· 1 shared Jason P. WongiD· 1 shared Jill S. Barnholtz-Sloan· 1 shared Jingqin Luo· 1 shared Jingqin Rosy LuoiD· 1 shared Joshua B Rubin· 1 shared

Activity by Year

2017-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Albert H. Kim

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

EGR1 drives sex-differences in glioblastoma tumorigenicity

Thamara J. Abouantoun, Lorida Llaci, Jason P. Wong, Lihua Yang, Nicole M. Warrington, Lloyd Tripp, Jingqin Rosy Luo, Brian D. Muegge, Joshua B. Rubin, Robi David Mitra

This study identifies EGR1 as a key driver of sex differences in glioblastoma tumorigenicity, showing it mediates survival and treatment response differences between males and females.

bioRxiv · May 16, 2025 · PreprintCancer Biology

Clinically Important sex differences in GBM biology revealed by analysis of male and female imaging, transcriptome and survival data

Wei Yang, Nicole M. Warrington, Sara J. Taylor, Eduardo Carrasco, Kyle W. Singleton, Ningying Wu, Justin D. Lathia, Michael E. Berens, Albert H. Kim, Jill S. Barnholtz-Sloan, Kristin R. Swanson, Jingqin Luo, Joshua B Rubin

The paper identifies sex-specific molecular subtypes of glioblastoma and shows that temozolomide is more effective in female patients, suggesting sex-specific treatment approaches could improve outcomes.

bioRxiv · Dec 12, 2017 · PreprintCancer Biology